Standout Papers

Comparison of PAM50 Risk of Recurrence Score With Onco<i>type</i> DX and IHC4 for Predicting Risk ... 2013 2026 2017 2021 426
  1. Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy (2013)
    Mitch Dowsett, Ivana Šestak et al. Journal of Clinical Oncology

Immediate Impact

4 from Science/Nature 56 standout
Sub-graph 1 of 19

Citing Papers

Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Pan-cancer single-cell dissection reveals phenotypically distinct B cell subtypes
2024 Standout
3 intermediate papers

Works of Carl Schaper being referenced

Prediction of Response to Neoadjuvant Chemotherapy Using Core Needle Biopsy Samples with the Prosigna Assay
2015
Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens
2014
and 5 more

Author Peers

Author Last Decade Papers Cites
Carl Schaper 1100 730 331 485 26 1.6k
Susan Cleator 788 977 350 699 45 1.9k
Kenneth Leung 608 554 395 1227 34 2.1k
Jiangchun Xu 650 419 765 1161 27 2.3k
K. Haider 569 1050 262 182 38 1.3k
W. P. Peters 515 1057 254 313 59 1.9k
Jillian Temple 594 502 179 854 16 2.0k
S. Nicholas Agoff 476 817 448 526 31 2.2k
Iain Beehuat Tan 722 855 402 1146 69 2.2k
Claude Allasia 520 714 178 868 58 1.8k
R.-D. Hesch 1250 653 501 877 24 1.9k

All Works

Loading papers...

Rankless by CCL
2026